Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emtricitabine in HIV-Infected Pediatric Subjects
NCT00642291Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Nov 2002
- Primary completion
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emtricitabine in human immunodeficiency virus infection (HIV), sponsored by Gilead Sciences. Started Nov 2002; status: completed.
02
Drugs
emtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00642291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642291.